Skip to main content
Quest Diagnostics

HIV Drug Resistance Testing for Contemporary ART

ASM Microbe 2024

American Society for Microbiology

Atlanta, GA, June 13-17, 2024

Oral presentation: HIV Drug Resistance Testing for Contemporary ART

Authors: Kagan R

Specialty: Infectious disease

Related content

Publication
Insights into HIV-1 transmission dynamics using routinely collected data in the Mid-Atlantic United States
Publication
The ongoing impact of COVID 19 on testing for and diagnoses of HIV and bacterial sexually transmitted infections in Oregon
Test FAQ
HIV-1 Integrase Genotype

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.